CLINICAL_TRIALS
trial_result
· 2018-06-21
Clinical Trial Update: PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes
Summary
The PROMASTER prospective cohort study investigating stratification and extreme response mechanisms in diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Diabetes | Status: COMPLETED